Ireland
--:--IST
Clinical Trials in the EU / 2026-527632-13-00
Authorised, not yet recruiting Phase I

Pharmacokinetics, safety and tolerability of tramadol after multiple-dose

2026-527632-13-00 · tracked via the Priya Life Science EU tracker
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Not possible to specify
Decision date
13/10/2026
Enrollment target
8
Sites
Spain

Condition studied

healthy participants

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-527632-13-00 on CTIS ↗ ← All trials in the EU